Biotech stocks rally on drug innovation; analysts point to ETFs and stocks

CNBC reports biotech stocks are rallying on clinical trial wins, acquisitions and new drug technologies. The article lists ETFs and stocks analysts favor for investors.

Timeline

1. 24 Oct, 18:56 UTCFirst appeared on CNBC

Top sources

• Biotech stocks are surging. How investors can play the new drug innovation boomCNBC